Moreover, Major-Monfried et al. showed that the Hartwell algorithm, based on serum levels of REG-3 α and s-ST2, when assayed 7 days after the onset of a-GVHD, can stratify patients at risk of 1 year TRM better than other clinical scores (10). The gene discussed is IL1RL1; the disease is graft versus host disease.